MedTrace Logo

Comparing AlloDerm and DermACELL in Breast Reconstruction

NCT04710537 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2022-08-04

No results posted yet for this study

Summary

This study will compare 90-day complication rates between breasts reconstructed with tissue expanders and AlloDerm vs. DermACELL, with each patient serving as her own comparator.

Conditions

  • Acellular Dermal Matrix in Breast Reconstruction

Interventions

OTHER

AlloDerm

Enrolled patients will have one of their breasts reconstructed with AlloDerm at the time of their breast reconstruction surgery.

OTHER

DermACELL

Enrolled patients will have one of their breasts reconstructed with DermACELL at the time of their breast reconstruction surgery.

Sponsors & Collaborators

Principal Investigators

  • Steven P Davison, MD · Sibley Memorial Hospital

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-21
Primary Completion
2022-07-26
Completion
2022-07-26

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04710537 on ClinicalTrials.gov